Search results
- 22.45Add to watchlist+1.17 (+5.50%)At close:4:00 PM EDTThu. May 30, 202422.11 -0.34 (-1.51%)After hrs:7:13 PM EDTThu. May 30, 2024Nasdaq Real Time Price (USD) · Market closed
- Open21.54High22.56Low21.38
- Mkt Cap1.08BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close21.2852 Wk. Low12.3252 Wk. High32.10
Related stocks
Find the latest Cassava Sciences, Inc. (SAVA) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Stock Forum & Discussion
Find the latest Cassava Sciences, Inc. (SAVA) stock...
- Latest Stock News & Headlines
Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright...
- Press Releases
Cassava Sciences Announces Over $125 Million Raised from...
- Statistics
Find out all the key statistics for Cassava Sciences, Inc....
- Holders
Find out the direct holders, institutional holders and...
- Financials
Get the detailed quarterly/annual income statement for...
- Profile
See the company profile for Cassava Sciences, Inc. (SAVA)...
- Stock Forum & Discussion
2 days ago · Should You Buy or Sell Cassava Sciences Stock? Get The Latest SAVA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (512) 501-2444
- 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260, AUSTIN TX, 78731
- ir@paintrials.com
See Cassava Sciences, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.
Get the latest Cassava Sciences Inc (SAVA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Find out the average price target, upside potential, and analyst ratings for SAVA based on 2 Wall Street analysts' predictions in the past 3 months. Compare SAVA with other healthcare stocks and see the earnings and sales forecasts for the next quarter.
What are your Cassava Sciences, Inc. (SAVA) stock predictions? 2 Wall Street analysts have issued ratings. Currently, 2 analysts rated SAVA as Bullish, 0 rated it Bearish, and 0 rated it...
Cassava Sciences is a biotech company developing drugs and diagnostics for Alzheimer's disease. The stock price, financial data, news and analysis, and industry overview are provided by The Motley Fool.